Tiefenbacher Group Mental Health Day

Tiefenbacher Group Mental Health Day

Prioritizing Mental Health in a Busy World

In honor of World Mental Health Day this October, Tiefenbacher Group organized a “Mental Health Awareness Day” for all our employees at AET Laboratories in Hyderabad, India. During this virtual session, a skilled medical practitioner shared invaluable insights on the importance of mental health and well-being.

In a world often driven by constant demands and responsibilities, it’s easy to overlook the significance of mental health. At Tiefenbacher Group, we believe that fostering a culture of mental well-being and work-life balance is essential to the happiness and productivity of our teams.

Thank you to our employees at AET Laboratories in Hyderabad

We are proud to share that over 100 employees joined with enthusiasm and genuine interest, demonstrating a collective commitment to personal growth and resilience. Supporting each other through awareness and open conversation strengthens not only our teams but also our ability to deliver with dedication and clarity.

Together, we are building a workplace where mental health is valued, and well-being is prioritized.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group employee benefits

Tiefenbacher Group employee benefits

The Tiefenbacher Group employee benefits programme in Hamburg offers a wide range of options for back care and prevention of back pain.

As a 100% family-owned leading healthcare company, we care about the health of our employees. That‘s why our worksite in Hamburg offers a variety of options for back care and back pain prevention.

For example, a half-hour of Yoga, Pilates, or back care is provided every Tuesday morning, under the professional guidance of Susann Gercken for all employees. These exercises help build and maintain deep core muscles and stretch muscles, tendons, and fascia, relieving stiffness and tension.

We spend most of our working day at our desks, using only a fraction of our body’s movement potential. Poor posture, such as leaning forward and raised shoulders, often leads to tension and back problems. Other parts of the body are barely used while sitting, causing muscles to shorten and fascia to become stiff.

Additionally to make the workday more dynamic, the Tiefenbacher Group provides height-adjustable desks at every workplace, desk bikes, and ergonomic stools.

If discomfort has already set in, employees at Tiefenbacher Group can seek professional treatment from physiotherapist Asja Bülow every Wednesday. She supports us with her expertise and experience, offering a range of holistic services from relaxation massages to personalized treatment.

Our primary goal as a company is to improve the lives of people around the world. We believe in starting with our own family by providing employees with the tools and knowledge they need to develop body awareness and to detect imbalances early and we all take a step toward well-being.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group celebrating Delorbis 10th Birthday

Tiefenbacher Group celebrating Delorbis 10th Birthday

Tiefenbacher Group celebrating a Decade of Excellence:

Tiefenbacher Group is delighted to announce a significant milestone in the journey of Delorbis Pharmaceuticals Ltd, our state-of-the-art manufacturing site and branded business on the beautiful island of Cyprus. This year, Delorbis celebrates its 10th anniversary, marking a decade of European excellence and meaningful contributions to the pharmaceutical industry.

On this special occasion, Delorbis hosted a celebratory event at their premises. Equally inviting not only dedicated employees but also close partners who have been a great support and an integral part of the success throughout the years. The day was filled with joy, accompanied by lively music, a vibrant cocktail bar, delicious food and of course, no birthday is complete without a magnificent birthday cake!

Delorbis turns 10

As we look back on these 10 years, we are proud of what Delorbis has achieved. From the humble beginnings to becoming a recognized name in the industry, Delorbis continues to uphold the highest standards in pharmaceutical manufacturing. We look forward to continuing our shared commitment to innovation, quality and pioneering healthcare to improve the lives of patients around the world.

Here’s to the next 10 years of groundbreaking advancements, partnerships, and continued success!

Tiefenbacher Group celebrating Delorbis 10th Birthday
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Featured Video Play Icon

Tiefenbacher Group CPHI Milan 2024

Tiefenbacher Group reflecting on incredible days at CPHI in Milan!

We had the pleasure of engaging in many inspiring conversations over the course of the three days, reconnecting with familiar faces and forming exciting new connections.

A highlight was our new booth where we introduced our current product portfolio and our innovations in raw materials, finished dosage forms and e-health solutions. It was perfectly designed for discussing new business ideas and exploring ways to make pharmaceuticals more affordable, more available and better than ever before in a professional environment!

A special thank you to our dedicated team and especially the organizing team. Specifically their hard work behind the scenes ensured everything ran smoothly both before and during the event. Your commitment to our mission of “pioneering healthcare” truly shone through.

Thank you again to everyone who visited us and took the time to meet with our experts. We look forward to continuing these conversations and shaping the future of healthcare together!

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Laboratories employees in India actively participated in Goonj’s material collection drives to support the victims of the Rahat floods.

Tiefenbacher Laboratories supports victims of Rahat floods

Tiefenbacher Laboratories employees in India actively participated in Goonj’s material collection drives to support the victims of the Rahat floods.

Tiefenbacher Group’s Hyderabad facility is a key player in our global operations, specializing in the development and manufacturing of complex generics and innovative formulations. With world-class labs and research capabilities, Tiefenbacher Laboratories ensures high-quality, affordable healthcare solutions. This makes Hyderabad an essential location for our pharmaceutical advancements.

International Day of Charity

We are proud that our employees in India are not only doing an excellent job but have also used the “International Day of Charity” to spend an entire week supporting Goonj, a non-profit organisation that focuses on rural development and poverty alleviation in India. Goonj repurposes urban discards for community-driven projects, impacting over 12 million lives in the last eight years. Our Hyderabad employees actively participate in Goonj’s material collection drives, donating essential items to support the victims of the Rahat floods and landslides.

While we continue to grow, Tiefenbacher Group remains dedicated to creating a positive impact, not only through healthcare but also by supporting meaningful community initiatives.

Tiefenbacher Laboratories employees in India actively participated in Goonj’s material collection drives to support the victims of the Rahat floods.
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Pioneering Healthcare at Tiefenbacher Group: Curiosity Driven, Excellence Focused, Patient Centered

Pioneering Healthcare at Tiefenbacher Group

Curiosity Driven, Excellence Focused, Patient Centered

At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose of making high-quality pharmaceuticals more affordable, more available, and better than ever before.

But what does it mean to be “excellence focused”? We asked our TIEFENBACHER API + INGREDIENTS Managing Director, Dr. Clemens Overlack, to elaborate:

“Excellence Focused” is one of the core values of Tiefenbacher Group. How does this commitment to excellence manifest in your day-to-day operations at TIEFENBACHER API & INGREDIENTS and how does it benefit your customers?

“An Active Pharmaceutical Ingredient (API) nowadays is a highly sophisticated product which has to conform to very stringent quality standards. From the beginning of our activities as distributors of APIs in 1963, we have thrived to ensure that these quality standards are always met. We supply from more than 100 carefully selected manufacturers around the world to whom we have had long-term relationships going back decades. These manufacturers are continuously monitored and audited by ourselves.

Our supply chain networks and infrastructure, for example a fully-fledged temperature-controlled warehouse with more than 1,500 pallet spaces as well as tightly controlled transportation routes, ensure that the quality of the APIs we supply is never compromised.

This focus on “better quality” ensures that our customers can fully rely on the standard of APIs we supply to them. It generates long-term trust which is vital in the supply of complex products such as APIs.”

Where do you see the future markets for APIs distributed by TIEFENBACHER API?

“Currently, TIEFENBACHER API supplies APIs to EU-based pharmaceutical companies with a focus on the German-speaking countries. However, quality standards for APIs are increasing worldwide. We therefore see a good chance to promote our high quality APIs to markets outside the EU, for example Middle East, Africa and Latin America. In all these markets we see strong growth.”

How does being a part of the TIEFENBACHER GROUP benefit TIEFENBACHER API?

“We already supply our high-quality APIs not only to external customers, but also to the group. At the same time, the technical and regulatory expertise available in the group helps us in our sourcing activities. We also develop strong networks through the group and can leverage this high expertise as well as the extended supplier base with our customers.”

At Tiefenbacher Group, the focus on excellence is the foundation of our pioneering approach to healthcare. We are excited about the future and remain committed to improving patients´ lives globally.

Feel free to reach out for more insights into our journey or to join us in pioneering the future of healthcare!

Pioneering Healthcare at Tiefenbacher Group: Curiosity Driven, Excellence Focused, Patient Centered
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group Celebrating World Pharmacists Day

Tiefenbacher Group Celebrating World Pharmacists Day

On this World Pharmacists Day, we at Tiefenbacher Group join the global community in celebrating the theme “Pharmacists: Meeting global health needs”.

This day, organized by the International Pharmaceutical Federation (FIP), highlights the vital role pharmacists play in enhancing healthcare systems worldwide —something we deeply value, as many of our own team members are certified pharmacists. Their expertise and dedication drive our mission to improve patients’ lives around the globe, making this day especially meaningful for us as a company.

Pharmacists Without Borders

In line with our commitment to healthcare, we proudly support Pharmacists Without Borders (“Apotheker ohne Grenzen Deutschland e.V.”) through financial contributions to their important projects. This partnership allows us to help deliver essential medicines and pharmaceutical expertise to those in need, especially in Ukraine.

Today, we honor pharmacists everywhere and reaffirm our dedication to initiatives that promote healthcare for all.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group New Market Launch: Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union

Tiefenbacher Pharmaceuticals New Market Launch: Ezetimibe/Atorvastatin

Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union

We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Ezetimibe/Atorvastatin in 12 European markets.

Tiefenbacher Pharmaceuticals Ezetimibe/Atorvastatin is a combination therapy that addresses two key factors contributing to high cholesterol levels:

Ezetimibe/Atorvastatin is used to reduce the production of cholesterol in the liver. Furthermore it helps to limit the absorption of cholesterol from the intestines. This dual action approach has the potential to lower LDL cholesterol (“bad” cholesterol), which could offer cardiovascular benefits, particularly for patients at risk of heart disease or stroke. The combination of Atorvastatin and Ezetimibe is a treatment option that is frequently considered by healthcare providers to treat patients with high cholesterol, especially those who are unresponsive to single-agent therapy. By offering this affordable medicine, we are providing a valuable option for those in need. At the same time, we can really make a difference in improving the lives of patients. The tablets are marketed in the strengths of 10mg/10mg, 10mg/20mg, 10mg/40mg, and 10mg/80mg

This launch reflects our ongoing commitment to providing patients with high-quality, cost-effective medications and is a testament to the hard work and commitment of our team

In case of inquiries please reach out to licensing@tiefenbacher.com 

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.  

For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at  info@tiefenbacher.com or visit us on  www.tiefenbacher-pharmaceuticals.com

Tiefenbacher Group New Market Launch: Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company. We are providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Tiefenbacher Group International Night

Tiefenbacher Group International Night 2024

Tiefenbacher Group celebrates 3rd International Night

We are thrilled to look back on our 3rd International Night, an annual tradition that celebrates all international employees who have joined the Tiefenbacher Group in Hamburg this year. It was a wonderful evening filled with culture, connection, and collaboration.

This evening began with an insightful tour at the Hamburger Kunsthalle (Art Hall Hamburg). Where an English-speaking guide introduced the group of new employees together with the members of management and HR to the rich art and history of this exciting city. After that they enjoyed a scenic walk along the Alster, taking in the beauty of Hamburg’s iconic views.

Art Hall, City Tour, Dinner

The day concluded with a lovely dinner. Providing the perfect opportunity for our new colleagues to share their experiences, discuss any challenges they may have faced while settling into Hamburg, and connect with the management team and HR. From navigating the city to practical matters like driver’s licenses, we are here to help you every step of the way.

This event truly embodies the international spirit of our company, and we were delighted to welcome our new team members in such a special way. We look forward to continuing this tradition and supporting our global team as they settle into their new home in Hamburg.

Tiefenbacher Group International Night
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com


Exciting News: Tiefenbacher Group Earns EcoVadis Silver Medal!

Tiefenbacher Group Earns EcoVadis Silver Medal!

Exciting News: Tiefenbacher Group Earns EcoVadis Silver Medal!

We are thrilled to announce that Tiefenbacher Group has been awarded the EcoVadis Silver Medal, highlighting our strong commitment to sustainability across the board.

This achievement is a testament to the hard work and dedication of our teams at Tiefenbacher Pharmaceuticals, Tiefenbacher Laboratories, and Delorbis Pharmaceuticals Ltd . The silver medal places us in the top 15% of companies assessed by EcoVadis globally, reflecting our advanced performance in key areas of sustainability:

  • Environment
  • Labor & Human Rights
  • Ethics
  • Sustainable Procurement

EcoVadis, the world’s largest provider of business sustainability ratings, evaluates how well companies integrate sustainability principles into their business and management systems. We are proud to have reached the 85th+ percentile, underscoring the maturity of our sustainability practices.

At TIEFENBACHER GROUP, we recognize that our responsibility as a global healthcare leader extends beyond medicine. We are committed to making a positive impact on society and our planet, and we will continue to push forward in our sustainability journey.

A huge thank you to our incredible colleagues for their ongoing contributions to this achievement! Together, we are making a difference.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world:

We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com